What does HAMB stand for?

HIV and AIDS Malignancy Branch (US NCI)

This definition appears very rarely and is found in the following Acronym Finder categories:

Military and Government

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Home Against Medical Advice Human Anti Murine Antibodies (cancer) Human Anti-Monoclonal Antibody Human Anti-Mouse Antibody (aka Human Anti-Murine Antibody) Hmong American Mutual Assistance Association (Minneapolis, MN) Hispanic American Medical Association of Houston (Texas) Hispanic American Medical Association of Louisiana, Inc. (New Orleans, LA) Islamic Resistance Movement (Arabic acronym meaning zeal) National Hispanic Academy of Media Arts and Sciences Hawaii Association of Mortgage Brokers (Honolulu, HI)		Hokey Ass Message Board Horrible Architectural Materials Better Off Not Existing Awards Houston-Area Molecular Biophysics Program (collaborative graduate program with biophysics faculty from six Houston-area, TX, universities) Houston Area Mountain Bike Riders Association (Texas) Harbin Aircraft Manufacturing Company (aka Harbin Aircraft Manufacturing Corporation; China) Harbin Aircraft Manufacturing Corporation (China) Heart of America Medical Center (Rugby, ND) Hell's Angels Motorcycle Club High and Mighty Color (band) Housing Authority of Maricopa County (Phoenix, AZ)

Samples in periodicals archive:

Little, MD, is a Senior Clinical Investigator; and Robert Yarchoan, MD, is Chief of the HIV and AIDS Malignancy Branch of the Center for Cancer Research al the National Cancer Institute.

The use of antiretroviral therapy in patients undergoing treatment ...

Most recently he was a senior clinical investigator in the developmental chemotherapy section of the NCI's investigational drug branch in the cancer therapy evaluation program, as well as an attending physician of the HIV and AIDS malignancy branch of the intramural Clinical Cancer Research program.

MedImmune Announces Executive Promotion and Appointments

2 The HIV and AIDS Malignancy Branch of the National Cancer Institute performed the trial, in collaboration with the University of Florida and the University of South Florida/All Childrens Hospital.

Early testing can predict effects of drugs on kids